A review of new, successful treatment options for the novel coronavirus.
The technology behind remote cardiac device monitoring is becoming more convenient, responsive and connected across the digital ecosystem—including a new smartphone app.
The absence of any of these disciplines can lead to blind spots that can introduce risk, but they are not all created equal.
No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
Moving too quickly in the product development process can lead to mistakes.
An upcoming webinar will discuss the new methods and protocols that have emerged as a result of conducting trials and HF studies during the pandemic.
To avoid delays in timelines, companies should develop IFU cleaning instructions with the worst-case clinical use and contamination method in mind.
The pandemic is helping realize the potential of ISO IDMP data standards in relation to adverse event reporting, electronic prescribing and medicines control in the supply chain.
The PCR and real-time PCR molecular diagnostics was valued at $4 billion in 2019.
Medical device security needs to address the cyber-physical threats, not just patient health information risk.